Browse studies
Find your next paid study
14 recruiting studies matching your filters
Phase 3
Effectiveness and Safety of Sotagliflozin in Slowing Kidney Function Decline in Persons With Type 1 Diabetes and Moderate to Severe Diabetic Kidney Disease
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available…
Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1+1 more
Estimated
~$10 – $7,500
Alessandro DoriaNCT06217302
Phase 1
A Phase 1, Multicenter, Parallel-Design, Single Dose, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Eloralintide in Participants With Severe Renal Impairment and End Stage Renal Disease (ESRD) Compared With Participants With Normal Renal Function
The purpose of the study is to assess the amount of Eloralintide (LY3841136) that reaches the bloodstream and the time it takes for the body to get rid of it w…
Kidney DiseaseRenal Insufficiency ChronicKidney Failure, Chronic+3 more
Estimated
~$10 – $7,500
Eli Lilly and CompanyNCT07426380